Amin W, Enam S, Sufiyan S, Ghias K, Bajwa M, Ilyas S
PLoS One. 2024; 19(9):e0311308.
PMID: 39348350
PMC: 11441661.
DOI: 10.1371/journal.pone.0311308.
Tu W, Feng M, Zhou Q, Wang Y, Wan M, Gong D
Exp Ther Med. 2024; 28(3):357.
PMID: 39071901
PMC: 11273358.
DOI: 10.3892/etm.2024.12646.
Peng W, Chen L, Liu J
Toxicol Res (Camb). 2023; 12(3):392-399.
PMID: 37397926
PMC: 10311132.
DOI: 10.1093/toxres/tfad024.
Wang W, Li W, Pan L, Li L, Xu Y, Wang Y
Biology (Basel). 2023; 12(3).
PMID: 36979179
PMC: 10045452.
DOI: 10.3390/biology12030488.
Posner M
Biosci Rep. 2022; 42(2).
PMID: 35132992
PMC: 8881648.
DOI: 10.1042/BSR20211248.
miRNAs derived from plasma small extracellular vesicles predict organo-tropic metastasis of gastric cancer.
Zhang C, Yang J, Chen Y, Jiang F, Liao H, Liu X
Gastric Cancer. 2022; 25(2):360-374.
PMID: 35031872
DOI: 10.1007/s10120-021-01267-5.
Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1.
Zhao Y, Jin L, Zhang X
Aging (Albany NY). 2021; 13(14):18498-18514.
PMID: 34292880
PMC: 8351670.
DOI: 10.18632/aging.203298.
The N-terminal domain of the adaptor protein p140Cap interacts with Tiam1 and controls Tiam1/Rac1 axis.
Chapelle J, Baudino A, Torelli F, Savino A, Morellato A, Angelini C
Am J Cancer Res. 2021; 10(12):4308-4324.
PMID: 33415001
PMC: 7783762.
The p140Cap adaptor protein as a molecular hub to block cancer aggressiveness.
Salemme V, Angelini C, Chapelle J, Centonze G, Natalini D, Morellato A
Cell Mol Life Sci. 2020; 78(4):1355-1367.
PMID: 33079227
PMC: 7904710.
DOI: 10.1007/s00018-020-03666-w.
SRCIN1 Regulated by circCCDC66/miR-211 Is Upregulated and Promotes Cell Proliferation in Non-Small-Cell Lung Cancer.
Hong W, Yu S, Zhuang Y, Zhang Q, Wang J, Gao X
Biomed Res Int. 2020; 2020:5307641.
PMID: 32964035
PMC: 7501558.
DOI: 10.1155/2020/5307641.
Historical retrospective of the oncogene and new perspectives (Review).
Simatou A, Simatos G, Goulielmaki M, Spandidos D, Baliou S, Zoumpourlis V
Mol Clin Oncol. 2020; 13(4):21.
PMID: 32765869
PMC: 7403812.
DOI: 10.3892/mco.2020.2091.
Temporally Altered miRNA Expression in a Piglet Model of Hypoxic Ischemic Brain Injury.
Casey S, Goasdoue K, Miller S, Brennan G, Cowin G, OMahony A
Mol Neurobiol. 2020; 57(10):4322-4344.
PMID: 32720074
PMC: 7383124.
DOI: 10.1007/s12035-020-02018-w.
Identification of Novel microRNA Prognostic Markers Using Cascaded Wx, a Neural Network-Based Framework, in Lung Adenocarcinoma Patients.
Kim J, Chun S, Park S, Lee S, Kim S, Hong J
Cancers (Basel). 2020; 12(7).
PMID: 32674274
PMC: 7409139.
DOI: 10.3390/cancers12071890.
Expression profiling of microRNAs and isomiRs in conventional central chondrosarcoma.
Parafioriti A, Cifola I, Gissi C, Pinatel E, Vilardo L, Armiraglio E
Cell Death Discov. 2020; 6:46.
PMID: 32566253
PMC: 7287106.
DOI: 10.1038/s41420-020-0282-3.
Isoliquiritigenin Derivative Regulates miR-374a/BAX Axis to Suppress Triple-Negative Breast Cancer Tumorigenesis and Development.
Peng F, Xiong L, Xie X, Tang H, Huang R, Peng C
Front Pharmacol. 2020; 11:378.
PMID: 32296334
PMC: 7137655.
DOI: 10.3389/fphar.2020.00378.
MicroRNA-665 promotes the proliferation of ovarian cancer cells by targeting SRCIN1.
Zhou P, Xiong T, Yao L, Yuan J
Exp Ther Med. 2020; 19(2):1112-1120.
PMID: 32010277
PMC: 6966142.
DOI: 10.3892/etm.2019.8293.
Long Non-Coding RNA MAGI2-AS3 is a New Player with a Tumor Suppressive Role in High Grade Serous Ovarian Carcinoma.
Gokulnath P, de Cristofaro T, Manipur I, Di Palma T, Soriano A, Guarracino M
Cancers (Basel). 2019; 11(12).
PMID: 31842477
PMC: 6966615.
DOI: 10.3390/cancers11122008.
miR-374a-5p: A New Target for Diagnosis and Drug Resistance Therapy in Gastric Cancer.
Ji R, Zhang X, Gu H, Ma J, Wen X, Zhou J
Mol Ther Nucleic Acids. 2019; 18:320-331.
PMID: 31614322
PMC: 6796712.
DOI: 10.1016/j.omtn.2019.07.025.
miR-373 promotes neuroblastoma cell proliferation, migration, and invasion by targeting SRCIN1.
Yuan X, Wen F, Chen X, Jiang X, Liu S
Onco Targets Ther. 2019; 12:4927-4936.
PMID: 31417287
PMC: 6593744.
DOI: 10.2147/OTT.S205582.
The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma.
Grasso S, Cangelosi D, Chapelle J, Alzona M, Centonze G, Lamolinara A
Cell Death Differ. 2019; 27(2):790-807.
PMID: 31285546
PMC: 7205889.
DOI: 10.1038/s41418-019-0386-6.